Medical Care in Beijing
for International Patients

GoBroad is China's most experienced commercial CAR-T programme, with over 1,000 cases completed under Dr. Kai Hu — one of northern China's most senior haematologists. The hospital covers a broader range of approved CAR-T targets than most centres, including dual-target constructs for multiply-relapsed cases. For haematological malignancies such as relapsed/refractory lymphoma, multiple myeloma, and ALL, it is consistently China Care's first recommendation in Beijing. The right hospital ultimately depends on your specific diagnosis — China Care reviews your case and recommends the most appropriate centre before you commit to travel.

For a diagnostic visit and initial consultation: 3–5 days. For CAR-T cell therapy: 4–8 weeks from admission, covering bridging chemotherapy, T-cell manufacturing (7–21 days), infusion, and post-infusion monitoring. For cancer surgery: 2–3 weeks. China Care provides a personalised timeline estimate before you travel.

Beijing Capital International Airport (PEK) handles the majority of international long-haul routes and is closer to most of Beijing's major hospitals. Beijing Daxing International Airport (PKX) is newer and serves additional international routes, particularly from Southeast Asia and the Middle East. China Care advises on which airport to use based on your departure city and arranges private transfers to the hospital on arrival.

Yes, during the T-cell manufacturing period (7–21 days between leukapheresis and infusion) many CAR-T patients are well enough to explore Beijing. The Forbidden City, Temple of Heaven, and the Great Wall are all accessible. China Care helps families plan this period and can recommend guides experienced in accompanying medical tourists. Any activity is always subject to your treating physician's guidance.

Beijing GoBroad Hospital accepts international patients from all countries, subject to an initial case review confirming that CAR-T therapy is clinically appropriate and that the patient is medically stable enough to travel. China Care submits your records for a remote pre-assessment before recommending travel. Patients from the US, Canada, UK, Australia, the Middle East, and Southeast Asia have all been treated at GoBroad through China Care's programme.

Yes. Once a hospital confirms your case is appropriate, China Care coordinates your appointment dates, admission, and every consultation in between. As an independent concierge, we are not affiliated with any single hospital — our recommendation is based on clinical fit for your case, not a referral arrangement.

Yes. All incoming records — pathology, imaging, and prior treatment history — are translated into Chinese for the hospital, and all outgoing reports, treatment plans, and discharge summaries are translated into English by a professional medical translator, not machine translation alone.

Yes. One family member may apply for an S1 visa to accompany the patient, prepared alongside the patient's own visa application. GoBroad Hospital provides private international-wing rooms with an adjacent suite for family members during treatment.

Yes. China Care recommends suitable accommodation within 10–20 minutes of your hospital and arranges airport transfers on arrival. In-hospital international-wing rooms are also available at GoBroad for patients who prefer to stay on-site during treatment.

Costs vary widely by treatment: commercial CAR-T therapy is typically $125K–$215K, cancer surgery $12K–$22K, and executive health screening $1,000–$1,400. These are indicative ranges — China Care provides a written, itemised estimate specific to your diagnosis and chosen hospital before you commit to travel.

All coordination, translation, and interpretation is provided in English. Beijing's partner hospitals and screening centres maintain English-speaking international patient departments; China Care's coordinators are also on hand for real-time interpretation during consultations and ward rounds where needed.